For funded healthcare founders

Advice is everywhere. Judgment isn't.

Healthcare changed in three directions at once. Capital concentrated. Buyers got harder to move. AI reset what good looks like. Most playbooks were written for a market that no longer exists.

We work the commercial and capital questions with you. Who buys. How to sell. When to raise. And which of the standard answers doesn't apply to your company.

The vision is yours. The navigation is ours.

Or book a working session

Paid, and you leave with a next step.

Twenty years across healthcare startups, health systems, and capital. From inside and alongside some of the best.

Mount Sinai
Cleveland Clinic
Samsung
Novo Nordisk
J.P. Morgan
Blueprint Health
Atlantic Health Venture Studio
Mayo Clinic
Northwell
Junto Health
NewYork-Presbyterian
Cedars-Sinai
Pfizer
Philips

What you're navigating now

Capital concentrated

  • More dollars, fewer rounds
  • Seed wants revenue, not promise
  • Series A wants a motion that runs without you

Buyers under pressure

  • Budgets squeezed and contested
  • Committees got bigger and slower
  • Saying no costs them nothing

AI moved the goalposts

  • Offense and defense at the same time
  • Your AI story has to survive diligence
  • The company you're benchmarked against may not exist yet

That's the gap we work in.

What you're weighing right now

  • Sell it yourself longer, or hire the leader your board keeps asking about.
  • Take the pilot in front of you, or hold out for the contract.
  • Raise on the proof you have, or spend two quarters building more.
  • Move fast on AI, or make sure the story holds up under scrutiny.
  • Chase the revenue in front of you, or focus the segment.

Pick the milestone.
We'll work backwards from it.

Companies don't hire us for advice. They hire us to get somewhere specific by a specific date. Usually the one that shapes the next three years. Four things people come to us for.

Revenue that repeats

Product works, customers you closed yourself, nothing repeats yet. We build a motion that's durable and predictable rather than a run of favors.

Usually six months.

Ready for Series A or B

Some revenue, next round nine to fifteen months out. We build the motion and the traction story from the same facts, so diligence finds one company instead of two.

Usually six to nine months.

A new market or segment

A buyer you haven't cracked yet. A health system, a payer, a pharma partner, a large employer. We build the strategy, find the budget owner, and turn a pilot into a contract.

Usually six months.

A board-level call

One decision that sets the direction. An exit conversation getting real, a flagship partnership, US market entry. Nothing we earn is contingent on the outcome, which is why we can say not yet.

Ninety to a hundred and twenty days, designed to end.

We've sat on every side of this table. Including yours.

The buyer's chair

Built and ran the Atlantic Health Venture Studio, deploying $40M into ten venture funds across eight managers plus a direct fund, and co-developing with 5,500 clinicians. Wrote every investment memo the committee decided from.

The investor's chair

J.P. Morgan, then nearly $1B in reinvestments at a private family office. Three limited partner advisory committee seats today.

The builder's chair

General Partner and Executive Director at Blueprint Health, running four cohorts that launched 45 venture-backed companies, eight of which exited to acquirers including UnitedHealth and Flatiron. Founded Junto Health, which worked with more than 60 organizations including Mayo Clinic, Cleveland Clinic and Pfizer, and built a US market-entry accelerator for the Government of Canada.

15

years in healthcare

45

companies launched across four accelerator cohorts

86

put in front of their buyer

$40M

deployed

Twenty years of health system C-suites, payer and pharma leaders, corporate venture teams, and name-brand fund partners. When an introduction moves your deal, you get it. It's never the product.

You define the problem or the opportunity. We design the system that solves it.

You bring

The company, the relationships, the decisions.

We bring

The method, the pattern recognition, the pressure test, the network.

Together we build

The system, on your live deals, not in a workshop.

You keep

A commercial engine that runs without us.

The measure of a good engagement is that you need us less at the end of it than you did at the start. We're not building a dependency you have to keep paying for. We're building a capability that stays in the company, which is also the only version that survives diligence.

We start with better questions.

The reason sell more feels unfixable is that selling isn't one skill. It's five systems working together, and usually one of them is leaking.

This is how we think, not a template we install. Most of the value is you starting to see your business this way too.

Target Who buys, and why do they say yes?

Each system feeds the others. We find the leak.

What founders say.

Excellent listener who quickly understood our product and provided insightful feedback from the lens of investors we are looking into. I cannot recommend him enough!
Swift SoundHubble · 5.0
He brings decades of wisdom, clarity, and strategic depth that immediately elevate everything he touches.
Dan Tobin, Founder/CEO, ElumaHubble · 5.0
He is sharp, direct, and provides actionable value. Five stars isn't enough.
Ruth KreshaHubble · 5.0
His perspective helped sharpen my thinking in real time.
Vivien RayamHubble · 5.0
Amazing accomplishments at Atlantic in only 3 years. Through your vision and hard work Atlantic will be benefiting for years to come with returns on these investments and the incredible partners you introduced.
Kevin Lenahan, CPA, FHFMA, former EVP and CFO, Atlantic Health System

Founders we know especially well.

Clinician founders.

  • You stay the clinical authority. We build the commercial engine with you.
  • Half the startups we've worked with were founded by clinicians.
  • If you survived organic chemistry, you can learn this.

Founders entering the US market.

  • US healthcare buys differently, and you can't build twenty years of buyer knowledge from abroad.
  • We created and ran a national US-entry accelerator for the Government of Canada.
  • Same five systems, aimed at your US entry.

Founders raising into a harder market.

  • The proof required for a round went up while the checks got more concentrated.
  • If your traction story has to hold up in diligence, it should be built alongside the traction, not written after it.

Experts on demand

Experts on demand.

One deep-dive a month, included. We bring in senior people from twenty years of rooms, briefed on your business, and we pay them, so they show up ready to work your real question.

The founder-turned-banker

Sold his company, left eight figures on the table, then built an investment bank so founders don't repeat his mistake.

The health-system CFO

Has approved, and killed, nine-figure budgets. Knows exactly what your buyer's spreadsheet says.

The hospital CIO

Has sat through a thousand vendor pitches. Will tell you in ten minutes why yours stalls.

The pharma BD lead

Has signed the co-development deals you're chasing, from the other side of the table.

The enterprise closer

Has personally sold tens of millions in revenue into health systems.

The clinician executive

Has chaired the committees that say yes, and the ones that quietly say no.

The fund partner

Reads a hundred decks a quarter. Will read yours the way your next investor will.

The payer executive

Has sat on the medical-policy and contracting committees that decide what gets covered, and what gets paid.

The strategic angel

A healthcare operator who writes checks. Has backed dozens of early teams and knows which stories get funded.

The right one shows up when your work calls for them. That's the point of twenty years of relationships.

What we don't do

We don't become your sales team.

We build the target list with you, shape the approach account by account, and where my name opens a door I'll use it. You take the meeting and you keep the relationship, because the person who owns the customer is the person your investors are buying. What we won't be is a volume outbound function you rent.

We don't sell introductions.

The network is real and it opens when the match is real. It is never the product, and nothing we do is contingent on a deal closing.

We don't take contingent fees on your raise or your exit.

Nothing we earn is tied to whether you raise or sell, which makes us the one voice in the room that can say not yet.

We don't hand you a report and leave.

The work happens with you, on your live deals, and ends with capability you keep.

Request a call.

Tell me where you are and what you're trying to reach. If it's a fit, I'll come back with times.

You'll get questions you probably haven't been asked, a straight read on where your five systems stand, and what I'd do next if it were mine.

If we shouldn't work together, I'll tell you that too, and you'll still leave with the answer you came for.

Or book a working session

Paid, and you leave with a next step.